Issue 144 • July 2024

UK’s new Netflix-style funding model for antibiotics goes live

The UK NHS has become the first system to permanently adopt a subscription payment model for new antibiotics.

Briefing

Genmab acquires biotechnology company ProfoundBio in $1.8bn deal

Feature

Swiss biotech ecosystem recuperates from global financial instability

Feature

Can supermarket pharmacies plug urgent healthcare gaps?

Comment

Moderna/MSD’s cancer vaccine may transform melanoma landscape